Physician profile
Robert B Moore
NPI 1063473049
$2,883.52
in general payments reported to CMS, 2019-2025
24 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $896 · 2021: $236 · 2022: $597 · 2023: $401 · 2024: $156 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $978.83 | 2019-2022 | |
| Inspire Medical Systems, INC. | $436.63 | 2020-2025 | Inspire |
| Glaxosmithkline, LLC. | $415.43 | 2022-2025 | Nucala |
| Optinose US, INC. | $219.31 | 2019-2025 | |
| Organogenesis INC. | $138.43 | 2021-2024 | Nushield |
| Regeneron Healthcare Solutions, INC. | $125.80 | 2021-2024 | Dupixent, Libtayo |
| Smith+Nephew, INC. | $76.86 | 2019-2024 | Stravix |
| Aerin Medical INC. | $73.35 | 2019-2025 | |
| Medtronic, INC. | $70.69 | 2023-2024 | Propel, Plasmablade(Tm), Bizact |
| Intersect Ent, INC. | $47.23 | 2019-2022 | |
| Aytu Biopharma, INC. | $41.89 | 2019 | |
| Olympus America INC. | $31.46 | 2019 | |
| Acera Surgical, INC. | $28.50 | 2025 | Restrata Wound Matrix |
| Checkpoint Surgical, INC | $27.44 | 2025 | Checkpoint Stimulators |
| Tactile Systems Technology INC | $20.63 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19.84 | 2025 | Tezspire |
| Acclarent, INC | $19.52 | 2023 | Trudi Nav Cable |
| Convatec INC. | $19.18 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.77 | 2024 | Voquezna |
| Genentech USA, INC. | $16.71 | 2019 | |
| Integra Lifesciences Corporation | $16.49 | 2024 | Microfrance, Codman Isocool Aht, Instruments-Orthopedic |
| Karl Storz Endoscopy-America | $14.11 | 2020 | |
| Kerecis Limited | $13.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cook Medical LLC | $12.79 | 2023 | Biodesign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.